Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT02411266 Completed - Clinical trials for Ischemic Preconditioning

Preconditioning With Limb Ischemia for Subarachnoid Hemorrhage

PreLIMBS
Start date: July 30, 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to learn about protecting the brain from dangerous low blood flow.

NCT ID: NCT02409602 Completed - Clinical trials for Postpartum Hemorrhage

Influence of BIIAL Following PPH on Dorsal Clitoral Artery Blood Flow and FSFI

Start date: October 2014
Phase: N/A
Study type: Observational

Dorsal clitoral artery Doppler examinations in women with bilateral internal iliac artery ligation due to postpartum hemorrhage (study group) and age-matched healthy puerperal women were performed regularly in the postoperative period, in order to evaluate possible effects of BIIAL on clitoral blood flow.

NCT ID: NCT02408965 Completed - Hemorrhage Clinical Trials

Uterotonic Prophylaxis Trial

UPT
Start date: March 2015
Phase: Phase 4
Study type: Interventional

Excessive bleeding after dilation and evacuation (D&E) requiring interventions is common, occurring in approximately 30% of cases at one large abortion-providing clinic. Uterotonic prophylaxis at the time of D&E, particularly with methylergonovine maleate (MM), is a common practice among D&E providers despite nearly no evidence for its efficacy. Finding ways to decrease excessive bleeding after D&E has the potential both to improve patient safety and to reduce costs of provider-initiated interventions. The investigators propose a randomized, controlled trial to investigate the efficacy of MM prophylaxis versus placebo in decreasing excessive bleeding measured by a composite outcome among women undergoing D&E at 20 to 24 weeks.

NCT ID: NCT02407717 Completed - Hemorrhage Clinical Trials

Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer

Start date: April 2015
Phase:
Study type: Observational

Patients with cancer hospitalized for an acute medical illness have an increased risk of venous thromboembolic events. Although international guidelines suggest the use of thromboprophylaxis in these patients, the recommendations are based on studies which included a percentage of patients with cancer without primarily focusing on this high risk group. Since patients with cancer present an increased risk of bleeding complications it is critical to evaluate the safety of thromboprophylaxis in the cancer group. Recent studies suggest a limited use of thromboprophylaxis in these patients. The aim of this study is to evaluate the use, efficacy and safety of thromboprophylaxis in medical cancer patients hospitalized for an acute medical disease. Design: observational, prospective study Primary end-point: incidence of major and clinically relevant non major bleeding during hospitalization Secondary endpoints: frequency of use, doses and contraindications for pharmacological thromboprophylaxis; venous thromboembolic events up to three months after discharge

NCT ID: NCT02405663 Completed - Clinical trials for Complications; Cesarean Section

Methods of Placental Delivery and the Amount of Blood Loss During Cesarean Section

Start date: April 2015
Phase: N/A
Study type: Interventional

To compare between the effect of controlled cord traction and manual removal of the placenta on blood loss among women undergoing caesarean sections

NCT ID: NCT02403596 Completed - Clinical trials for Blood Loss After a Total Hip Replacement

Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban

ESPER
Start date: October 20, 2015
Phase: Phase 3
Study type: Interventional

This study evaluates the efficacy of tranexamic acid versus placebo on perioperative blood loss using two dosage regimens (standard and extended) after a surgery during total hip arthroplasty in patients receiving the novel fast-acting oral anticoagulant rivaroxaban for prophylaxis of thrombosis.

NCT ID: NCT02400697 Completed - Sepsis Clinical Trials

Placental Transfusion Project for Preterm Infants

Start date: September 2014
Phase: N/A
Study type: Observational

The American College of Obstetrics and Gynecology, American Academy of Pediatrics and the World Health Organization have recently published recommendations related to placental transfusions in preterm infants. This project will review outcomes of preterm infants following a quality improvement implementation process in several delivery centers in Indiana. Centers involved in this project are also part of the Indiana Vermont Oxford Network (IRB#1003-84). Data is recorded for that network and the investigators site will be reviewing that data every 3 months from infants who have completed the Vermont Oxford Network collection. This project will specifically look at the incidence of intraventricular hemorrhage, necrotizing entercolitis, periventricular leukomalacia, sepsis and death following the implementation of the ACOG recommendations.

NCT ID: NCT02396771 Completed - Clinical trials for Postpartum Hemorrhage

Effect of Uterine Massage Versus Sustained Uterine Compression on Blood Loss After Vaginal Delivery

Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to compare trans-abdominal uterine massage to sustained uterine compression after vaginal delivery with respect to blood loss and maternal pain. It is a randomized controlled trial that will be conducted at the American University of Beirut Medical Center - Delivery Suite.

NCT ID: NCT02393300 Completed - Total Blood Loss Clinical Trials

Comparison of Topical Versus Intravenous Tranexamic Acid in TKA

Start date: July 2014
Phase: Phase 3
Study type: Interventional

Previous studies in both the cardiovascular and orthopedic study have shown tranexamic acid (TXA) reduces blood loss and post-operative blood transfusion rate largely without major complications . In addition, many meta-analyses have confirmed these results . However, there is little information about comparison among the different routes of TXA administration in TKA. Therefore, this study has been designed to determine which administration route of TXA is more effective and safety.

NCT ID: NCT02391636 Completed - Clinical trials for Postpartum Hemorrhage

Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage

Start date: February 2015
Phase: Phase 4
Study type: Interventional

Double blinded randomized controlled study